Video Experimental Relacionado
Updated: Sep 10, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Pyopericardium neumocócico con osteomielitis xifoidea en el VIH / SIDA: una complicación rara pero potencialmente
Nihar Jena1, Izza Saeed1, Mackenzie Hamilton1
1Department of Interventional Cardiology, Marshall University, Huntington, West Virginia, USA.
La pericarditis purulenta, una infección rara, puede ocurrir en pacientes inmunocomprometidos. Este caso destaca el manejo exitoso del piopericardio neumocócico con tamponado cardíaco en un paciente con VIH.
Área de la Ciencia:
- Cardiología
- Enfermedades infecciosas
- Medicina de cuidados intensivos
Sus antecedentes:
- La pericarditis purulenta es una infección rara pero potencialmente mortal, que se observa cada vez más en personas inmunocomprometidas.
- El uso de antibióticos ha reducido su incidencia, pero las infecciones oportunistas siguen siendo un riesgo.
- A menudo surge de la propagación bacteriana secundaria.
Más Videos Relacionados
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
13:50Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Videos de Conceptos Relacionados
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumothorax-II
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: